- Home
- SDST vs ESLA Comparison
SDST vs ESLA Comparison
Compare SDST & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SDST | ESLA |
|---|---|---|
| Founded | 2022 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.9M | 48.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SDST | ESLA |
|---|---|---|
| Price | $3.49 | $1.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $17.00 | $16.00 |
| AVG Volume (30 Days) | 113.6K | ★ 243.3K |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.43 | $0.73 |
| 52 Week High | $70.25 | $3.15 |
Technical Indicators
Market Signals| Indicator | SDST | ESLA |
|---|---|---|
| Relative Strength Index (RSI) | 46.96 | 50.90 |
| Support Level | $3.06 | $1.52 |
| Resistance Level | $3.74 | $2.27 |
| Average True Range (ATR) | 0.32 | 0.31 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 53.57 | 59.04 |
Price Performance
Historical ComparisonAbout SDST Stardust Power Inc. Common Stock
Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.